Changes in pH differently affect the binding properties of histamine H1 receptor antagonists

被引:44
|
作者
Gillard, M [1 ]
Chatelain, P [1 ]
机构
[1] UCB Bioprod SA, In Vitro Pharmacol, B-1420 Braine Lalleud, Belgium
关键词
histamine H-1 receptor; antihistamine; binding; levocetirizine; desloratadine; fcxofenadine;
D O I
10.1016/j.ejphar.2005.11.051
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the effect of acidic pH, a condition that can be encountered during inflammation accompanying allergic reaction, on the binding properties of histamine H-1 receptor antagonists, including levocetirizine ((2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl} ethoxy)acetic acid; Xyzal (R)), fexofenadine (rac-2-[4-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl]butylphenyl]-2-methylpropionic acid hydrochloride; Allegral (R)) and desloratadine (8-Chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5.6]cyclohepta[1,2-b]pyridine; Clarinex (R)).). Lowering the pH from 7.4 to 5.8 decreased the affinity of [H-3]mepyramine for histamine H-1 receptors from 1.7 to 7.5 nM while the opposite was observed with [H-3]levocetirizine, whose affinity increased from 4.1 to 1.5 nM. Competition curves with [3 H]mepyramine indicated that decreasing the pH from 7.4 to 5.8 led to a 2- to 5-fold increase in the affinity of fexofenadine and levocetirizine, no change in affinity for desloratadine and a 5- to 10-fold decrease in affinity for mepyramine and histamine. Kinetic experiments showed that the increase in affinity of levocetirizine and, to a lesser extent, fexofenadine were totally attributable to a lower dissociation rate at acidic pH (t(1/2) increasing from 77 to 266 min and from 71 to 135 min, respectively). Although the affinity of desloratadine remained unchanged, lowering the pH caused a decrease in its dissociation rate (t(1/2) of 50 and 256 min at pH 7.5 and 5.8, respectively) accompanied by a concomitant 3.5-fold decrease in its association rate constant. The loss of affinity of mepyramine at acidic pH was driven by a decrease in its association rate constant. Interaction between the carboxylic A moiety of levocetirizine and Lys(191) is responsible for its slow dissociation rate from the receptor. We found that the magnitude of the pH effect on the dissociation rate of levocetirizine was maintained after mutating Lys(191) into alanine, suggesting that a tighter interaction of levocetirizine with Lys(191) at lower pH is not the cause of its even slower dissociation rate from the receptor. Although these changes may seem limited in amplitude, we show that they may have substantial effects on receptor occupancy in vivo. (c) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 50 条
  • [1] In silico binding characteristics between human histamine H1 receptor and antagonists
    Xiaojian Wang
    Qian Yang
    Minyong Li
    Dali Yin
    Qidong You
    Journal of Molecular Modeling, 2010, 16 : 1529 - 1537
  • [2] In silico binding characteristics between human histamine H1 receptor and antagonists
    Wang, Xiaojian
    Yang, Qian
    Li, Minyong
    Yin, Dali
    You, Qidong
    JOURNAL OF MOLECULAR MODELING, 2010, 16 (09) : 1529 - 1537
  • [3] Constitutive activity of the histamine H1 receptor reveals inverse agonism of histamine H1 receptor antagonists
    Bakker, RA
    Wieland, K
    Timmerman, H
    Leurs, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 387 (01) : R5 - R7
  • [4] Exploring the Effect of Cyclization of Histamine H1 Receptor Antagonists on Ligand Binding Kinetics
    Wang, Zhiyong
    Bosma, Reggie
    Kuhne, Sebastiaan
    van den Bor, Jelle
    Garabitian, Wrej
    Vischer, Henry F.
    Wijtmans, Maikel
    Leurs, Rob
    de Esch, Iwan J. P.
    ACS OMEGA, 2021, 6 (19): : 12755 - 12768
  • [5] Histamine H1 Receptor Antagonists Facilitate Electroacupuncture Analgesia
    Lin, Jaung-Geng
    Lee, Yu-Chen
    Tu, Cheng-Hao
    MacDonald, Iona
    Chung, Hsin-Yi
    Luo, Sih-Ting
    Hung, Shih-Ya
    Chen, Yi-Hung
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2018, 46 (01): : 55 - 68
  • [6] Clinical Pharmacology of New Histamine H1 Receptor Antagonists
    F. Estelle R. Simons
    Keith J. Simons
    Clinical Pharmacokinetics, 1999, 36 : 329 - 352
  • [7] Clinical pharmacology of new histamine H1 receptor antagonists
    Simons, FER
    Simons, KJ
    CLINICAL PHARMACOKINETICS, 1999, 36 (05) : 329 - 352
  • [9] STUDIES ON MODE OF ACTION OF HISTAMINE H1 RECEPTOR ANTAGONISTS AND H2-RECEPTOR ANTAGONISTS ON GASTRIC HISTAMINE METHYLTRANSFERASE
    BARTH, H
    NIEMEYER, I
    LORENZ, W
    AGENTS AND ACTIONS, 1973, 3 (03): : 138 - 147
  • [10] Suppression of osteopontin functions by histamine H1 receptor antagonists, in vitro
    Suzuki, M.
    Furuta, A.
    Kanai, K-, I
    Asano, K.
    Suzaki, H.
    ALLERGY, 2014, 69 : 135 - 135